DG
ABBV icon

DMC Group’s AbbVie ABBV Stock Holding History

DMC Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.44M Buy
6,631
+642
+11% +$142K 0.97% 28
2025
Q4 		$1.37M Buy
5,989
+223
+4% +$50.8K 0.91% 31
2025
Q3 		$1.34M Buy
5,766
+140
+2% +$28.5K 0.92% 29
2025
Q2 		$1.04M Sell
5,626
-37
-0.7% -$6.88K 0.81% 37
2025
Q1 		$1.19M Sell
5,663
-3
-0.1% -$583 0.97% 29
2024
Q4 		$1.01M Sell
5,666
-50
-0.9% -$9.19K 0.82% 38
2024
Q3 		$1.13M Sell
5,716
-36
-0.6% -$6.72K 0.91% 33
2024
Q2 		$987K Buy
5,752
+285
+5% +$47.2K 0.85% 43
2024
Q1 		$996K Buy
5,467
+28
+0.5% +$4.83K 0.86% 39
2023
Q4 		$843K Sell
5,439
-166
-3% -$24.2K 0.8% 43
2023
Q3 		$835K Hold
5,605
– – 0.78% 39
2023
Q2 		$755K Sell
5,605
-36
-0.6% -$5.28K 0.76% 46
2023
Q1 		$905K Buy
5,641
+870
+18% +$133K 0.91% 33
2022
Q4 		$775K Buy
4,771
+840
+21% +$129K 0.87% 36
2022
Q3 		$544K Sell
3,931
-112
-3% -$16.1K 0.66% 45
2022
Q2 		$621K Buy
4,043
+23
+0.6% +$3.52K 0.74% 41
2022
Q1 		$623K Buy
4,020
+177
+5% +$25.7K 0.7% 45
2021
Q4 		$522K Buy
+3,843
New +$454K 0.45% 64

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DMC Group's ABBV Position: Q1 2026 in Review

DMC Group increased its AbbVie (ABBV) stake by 11% in Q1 2026, buying an estimated $142K and bringing the position to 6,631 shares worth $1.44M. The position accounts for 0.97% of the portfolio, ranked #28.

DMC Group first reported a position in ABBV in Q4 2021 and has held it in 18 quarters since. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • DMC Group held 6,631 shares of AbbVie worth $1.44M as of Q1 2026.
  • DMC Group bought 642 AbbVie shares in Q1 2026, an estimated $142K.
  • AbbVie made up 0.97% of DMC Group's portfolio in Q1 2026, its #28 holding.
  • DMC Group first reported a position in AbbVie in Q4 2021 and has held it in 18 quarters since.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on DMC Group's 13F filing for Q1 2026, filed 30 Apr 2026.